ClinRé 001-022 (Premier Cancer Care and Infusion Center)

Fresno, California 93710

1 studies enrolling now · 2 studies all time

What they study most

Lung Cancer, Non-squamous, Non-small Cell, Non-small Cell Lung Cancer

Studies at this site

• Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations — Recruiting now
• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling